Average Co-Inventor Count = 10.30
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Institutes of Health, a Component of the US Dept. of Health & Human Services (16 from 3,435 patents)
2. Institute for Research in Biomedicine (3 from 56 patents)
3. Glaxosmithkline Biologicals Sa (1 from 531 patents)
4. Genvex, Inc. (1 from 1 patent)
16 patents:
1. 12458691 - HIV-1 ENV fusion peptide immunogens and their use
2. 12435113 - Prefusion PIV F immunogens and their use
3. 12275758 - Prefusion RSV F proteins and their use
4. 12053519 - HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
5. 11878998 - Prefusion RSV F proteins and their use
6. 11845778 - Prefusion PIV F immunogens and their use
7. 11780885 - Zika viral antigen constructs
8. 11602559 - HIV-1 Env fusion peptide immunogens and their use
9. 11174292 - Substitutions-modified prefusion RSV F proteins and their use
10. 11078239 - Prefusion PIV F immunogens and their use
11. 10898566 - Zika virus vaccines
12. 10759846 - Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
13. 10301377 - Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
14. 8323961 - HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
15. 7947822 - HIV vaccines based on Env of multiple clades of HIV